FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3034053981> ?p ?o ?g. }

• W3034053981 abstract "Abstract FKB327 was approved by the European Medicines Agency as a biosimilar to European‐authorized adalimumab (Humira ® ; AbbVie Inc). Adalimumab is a monoclonal antibody, binding and inhibiting tumor necrosis factor (TNF)‐α with use indicated for several immune‐mediated, chronic, and inflammatory disorders. The approval is based on high similarity in the physicochemical properties between FKB327 and adalimumab. The objective of this study is to assess the biological similarity, with regard to Fab‐ and Fc‐associated functions, and describe the relationship between physicochemical and biological characterization and functional activity. State‐of‐the‐art orthogonal techniques were implemented to assess the structure and function of FKB327. Peptide mapping with liquid chromatography and mass spectrometry, capillary electrophoresis–sodium dodecyl sulfate, ultraviolet circular dichroism, size‐exclusion high‐performance liquid chromatography (HPLC), and cation exchange HPLC were the techniques used to assess structure. Functional activity was assessed with enzyme‐linked immunosorbent assay, surface plasmon resonance, and cell‐based assays. The polypeptide sequence of FKB327 was identical to that of adalimumab. FKB327 also was demonstrated to have a similar secondary and tertiary structure to adalimumab. Posttranslational heterogeneities, along with size and charge variants, were not clinically meaningful. FKB327 binds to TNF‐α, FcγR, the neonatal Fc receptor, and C1q, and induces apoptosis, antibody‐dependent cellular cytotoxicity, and complement‐dependent cytotoxicity. The binding and activity of FKB327 were similar to that of adalimumab. FKB327 shares similar structure and activity with adalimumab. Based on characterization of physicochemical and biological properties, FKB327 is expected to have a similar safety, immunogenicity, and efficacy profile to adalimumab." @default.
• W3034053981 created "2020-06-12" @default.
• W3034053981 creator A5004179634 @default.
• W3034053981 creator A5049958633 @default.
• W3034053981 creator A5053782319 @default.
• W3034053981 creator A5081245780 @default.
• W3034053981 date "2020-06-01" @default.
• W3034053981 modified "2023-09-29" @default.
• W3034053981 title "Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab" @default.
• W3034053981 cites W1967570746 @default.
• W3034053981 cites W1971014721 @default.
• W3034053981 cites W1973083584 @default.
• W3034053981 cites W1973555453 @default.
• W3034053981 cites W1976821928 @default.
• W3034053981 cites W1982904104 @default.
• W3034053981 cites W2020840478 @default.
• W3034053981 cites W2020890137 @default.
• W3034053981 cites W2030746771 @default.
• W3034053981 cites W2048049691 @default.
• W3034053981 cites W2057446834 @default.
• W3034053981 cites W2060874457 @default.
• W3034053981 cites W2068410058 @default.
• W3034053981 cites W2107735396 @default.
• W3034053981 cites W2123847878 @default.
• W3034053981 cites W2136007354 @default.
• W3034053981 cites W2139039148 @default.
• W3034053981 cites W2151129660 @default.
• W3034053981 cites W2155819450 @default.
• W3034053981 cites W2198471696 @default.
• W3034053981 cites W2268576594 @default.
• W3034053981 cites W2766102779 @default.
• W3034053981 cites W2921608880 @default.
• W3034053981 cites W2945299140 @default.
• W3034053981 cites W2946371282 @default.
• W3034053981 cites W3006846120 @default.
• W3034053981 cites W4251433980 @default.
• W3034053981 doi "https://doi.org/10.1002/prp2.604" @default.
• W3034053981 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7272391" @default.
• W3034053981 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32500668" @default.
• W3034053981 hasPublicationYear "2020" @default.
• W3034053981 type Work @default.
• W3034053981 sameAs 3034053981 @default.
• W3034053981 citedByCount "9" @default.
• W3034053981 countsByYear W30340539812021 @default.
• W3034053981 countsByYear W30340539812022 @default.
• W3034053981 countsByYear W30340539812023 @default.
• W3034053981 crossrefType "journal-article" @default.
• W3034053981 hasAuthorship W3034053981A5004179634 @default.
• W3034053981 hasAuthorship W3034053981A5049958633 @default.
• W3034053981 hasAuthorship W3034053981A5053782319 @default.
• W3034053981 hasAuthorship W3034053981A5081245780 @default.
• W3034053981 hasBestOaLocation W30340539811 @default.
• W3034053981 hasConcept C106847996 @default.
• W3034053981 hasConcept C109316439 @default.
• W3034053981 hasConcept C126322002 @default.
• W3034053981 hasConcept C133571119 @default.
• W3034053981 hasConcept C155672457 @default.
• W3034053981 hasConcept C159654299 @default.
• W3034053981 hasConcept C171250308 @default.
• W3034053981 hasConcept C17991360 @default.
• W3034053981 hasConcept C185592680 @default.
• W3034053981 hasConcept C192562407 @default.
• W3034053981 hasConcept C202751555 @default.
• W3034053981 hasConcept C203014093 @default.
• W3034053981 hasConcept C2780132546 @default.
• W3034053981 hasConcept C542903549 @default.
• W3034053981 hasConcept C55493867 @default.
• W3034053981 hasConcept C59491497 @default.
• W3034053981 hasConcept C70721500 @default.
• W3034053981 hasConcept C71924100 @default.
• W3034053981 hasConcept C86803240 @default.
• W3034053981 hasConcept C98274493 @default.
• W3034053981 hasConceptScore W3034053981C106847996 @default.
• W3034053981 hasConceptScore W3034053981C109316439 @default.
• W3034053981 hasConceptScore W3034053981C126322002 @default.
• W3034053981 hasConceptScore W3034053981C133571119 @default.
• W3034053981 hasConceptScore W3034053981C155672457 @default.
• W3034053981 hasConceptScore W3034053981C159654299 @default.
• W3034053981 hasConceptScore W3034053981C171250308 @default.
• W3034053981 hasConceptScore W3034053981C17991360 @default.
• W3034053981 hasConceptScore W3034053981C185592680 @default.
• W3034053981 hasConceptScore W3034053981C192562407 @default.
• W3034053981 hasConceptScore W3034053981C202751555 @default.
• W3034053981 hasConceptScore W3034053981C203014093 @default.
• W3034053981 hasConceptScore W3034053981C2780132546 @default.
• W3034053981 hasConceptScore W3034053981C542903549 @default.
• W3034053981 hasConceptScore W3034053981C55493867 @default.
• W3034053981 hasConceptScore W3034053981C59491497 @default.
• W3034053981 hasConceptScore W3034053981C70721500 @default.
• W3034053981 hasConceptScore W3034053981C71924100 @default.
• W3034053981 hasConceptScore W3034053981C86803240 @default.
• W3034053981 hasConceptScore W3034053981C98274493 @default.
• W3034053981 hasFunder F4320321177 @default.
• W3034053981 hasIssue "3" @default.
• W3034053981 hasLocation W30340539811 @default.
• W3034053981 hasLocation W30340539812 @default.
• W3034053981 hasLocation W30340539813 @default.
• W3034053981 hasLocation W30340539814 @default.
• W3034053981 hasLocation W30340539815 @default.
• W3034053981 hasOpenAccess W3034053981 @default.

• next